Skip to main content
Premium Trial:

Request an Annual Quote

Intelligent Fingerprinting Gets CE Mark for Saliva-Based SARS-CoV-2 Test

NEW YORK — UK diagnostics firm Intelligent Fingerprinting said on Monday that it has received CE marking for its VSS-GP COVID-19 Saliva Test.

The lateral flow assay uses polyclonal antibodies to detect a SARS-CoV-2 antigen in saliva samples collected from inside of the cheek and provides a visual readout within 20 minutes. Intelligent Fingerprinting said that it has scaled up production capacity at its manufacturing facility and will be able to produce 4 million of the tests a month by the end of the year.

"We also anticipate working with a range of distribution partners to make this test available across multiple markets," Philip Hand, executive chairman of Intelligent Fingerprinting, said in a statement.

Originally founded to develop drug screening tests that use sweat from a person's fingerprint, Intelligent Fingerprinting began working on the saliva-based SARS-CoV-2 test when the Delta variant of the virus began spreading across the world.